Program: Saturday (23.10.2010)

14:00 – 15:30

Room: Severin
(Dorint Hotel)

Workshop HL in Adolescents: a Controversy?

  • Joseph Connors
  • Dieter Körholz
  • Treatment of Hodgkin Lymphoma: Comparison of Treatment Intensity and Ef cacy of Pediatric and Adult Protocols

    • Joseph Connors
    • Christine Mauz-Körholz
  • Hodgkin Lymphoma in Adolescents: French Experience and Conclusions

    • Peter Borchmann
  • Adolescents Are Biological Adults

    • Joseph Connors
  • Hodgkin Lymphoma in Adolescents and Young Adults Is Best Managed as an Adult Disease

    • Judith Landman-Parker

14:00 – 15:30

Room: Pipin II
(Dorint Hotel)

Workshop Interim PET in HL

  • Andrea Gallamini
  • Aaron Polliack
  • Towards Standardization of Scanning and Reporting of Results

    • Michael O'Doherty
  • Logistics of the Network of Imaging Exchange and the Review Panel

    • Michel Meignan
  • Interim PET and the Role of Radiotherapy in Early Stage Disease

    • Tim Illidge
  • Interim-PET in Tailoring Therapy in Early Stage HL – The EORTC-GELA-IIL Experience

    • Elly Lugtenburg
  • Interim-PET in the Therapeutic Strategy of Advanced Stage HL

    • Martin Hutchings
  • Interim-PET in Patients with Advanced HL Treated with Non-ABVD Regimens

    • Abraham Avigdor
  • Interim-PET During BEACOPP Chemotherapy: Experience of the GHSG

    • Markus Dietlein

14:00 – 15:30

Room: Pipin I
(Dorint Hotel)

Workshop Basic Research

  • Ralf Küppers
  • Anke van den Berg
  • Molecular Cytogenetic Studies in Hodgkin Lymphoma

    • Reiner Siebert
  • The role of KLF4 and FoxO1 in Hodgkin Lymphoma

    • Thomas Wirth
  • JAK2 Rearrangements, Including the Novel SEC31A-JAK2 Fusion, Are Recurrent in Classical Hodgkin Lymphoma

    • Wlodarska Iwona
  • HLA Expression and Genetic Associations in EBV Positive and EBV Negative Classical Hodgkin Lymphoma

    • Anke van den Berg
  • Immune Escape in Hodgkin Lymphoma and PTLD – the Role and Targeting of Galectin-1

    • Margaret Shipp

14:00 – 15:30

Room: Martin & Augustin
(Dorint Hotel)

Workshop Follow-Up in Long Term Survivors: Recommendations

  • John Raemaekers
  • Joachim Yahalom
  • Epidemiology Trends of HL in Sweden

    • Magnus Björkholm
  • Breast Cancer

    • Flora van Leeuwen
  • Lung Cancer

    • John Radford
  • Cardiovascular Screening

    • Louis S. Constine

14:00 – 17:30

Room: Pfau
(Dorint Hotel)

Workshop Social Medical Implication of Chronic Fatigue in HL

16:00 – 17:30

Room: Sandkaul
(Dorint Hotel)

Workshop HL Pathologists’ Meeting

  • Randy Gascoyne
  • Harald Stein
  • Methylation Pro ling of Mediastinal Gray Zone Lymphoma

    • Franziska Eberle
  • DNA Methylation Analyses in Hodgkin Lymphoma

    • Reiner Siebert
  • Mechanisms of Aberrant GATA-3 Expression in Classical Hodgkin Lymphoma

    • Jens Stanelle
  • Genome-Wide Copy Number Analysis of Microdissected HRS Cells in Classical Hodgkin Lymphoma

    • Christian Steidl

16:00 – 17:30

Room: Martin & Augustin
(Dorint Hotel)

Workshop NLPHL: Treatment Recommendations

  • Michele Ghielmini
  • Andrew Lister
  • The Optimal First Line treatment

    • Ranjana Advani
  • Options in Subsequent Relapses

    • Dennis A. Eichenauer
  • Radiotherapy Alone is Suf cient in Early Stage

    • Andrew Wirth
  • Chemotherapy Should Be Added to Radiotherapy in Early Stage

    • Joseph Connors

16:00 – 17:30

Room: Pipin I
(Dorint Hotel)

Workshop Defining RT Field and Dose

  • Theodore Girinsky
  • Lena Specht
  • Evidence for Radiotherapy in Early Stage Hodgkin Lymphoma, Volume and Dose – Review of the Meta-Analyses

    • Lena Specht
  • Evidence for Radiotherapy in Advanced Stage Hodgkin Lymphoma, Volume and Dose

    • Berthe Aleman
  • RT Dose in Early Stages – the GHSG Studies

    • Michael Fuchs
  • Reductions in Irradiated Volume in Hodgkin Lymphoma, IFRT and INRT

    • Theodore Girinsky
  • Is INRT Suitable for Pediatric Patients?

    • Louis S. Constine
  • Highly Conformal Radiotherapy for Hodgkin Lymphoma, IMRT, Arc Therapy, Proton Therapy

    • Brad Hoppe
  • Imaging for Highly Conformal Radiotherapy for Hodgkin Lymphoma

    • Staphanie Terezakis
  • Uncertainties in Highly Conformal Radiotherapy for Hodgkin Lymphoma

    • Lena Specht
  • Panel Discussion and Proposal for an ‘International Forum for Lymphoma Radiation Oncologists’

    • Joachim Yahalom

16:00 – 17:30

Room: Severin
(Dorint Hotel)

Workshop HL in Non-Western Countries

  • James Armitage
  • Andreas Engert
  • Hodgkin Lymphoma in Non-Western Countries: Pathology

    • Elaine Jaffe
  • Hodgkin Lymphoma in Non-Western Countries: Africa

    • Peter Jacobs
  • Hodgkin Lymphoma in Non-Western Countries: South America

    • Carlos Chiattone
  • Hodgkin Lymphoma in Non-Western Countries: Middle East

    • Hamdy Abdel Azim
  • Hodgkin Lymphoma in Non-Western Countries: China

    • Wenqi Jiang

16:00 – 17:30

Room: Pipin II
(Dorint Hotel)

Workshop Lymphoma Response Evaluation

  • Bruce Cheson
  • Anas Younes
  • Response Assessment in Clinical Practice and Clinical Research

    • Anas Younes
  • Experience with PET in Hodgkin Lymphoma

    • Martin Hutchings
  • Current Risk Adapted Clinical Trials in Hodgkin Lymphoma

    • John Radford
  • Recent Modi cations of the International Response Criteria for Lymphoma

    • Bruce Cheson
  • New Directions in Imaging for Lymphoma

    • Lale Kostakoglu

Archive

You a viewing the program of a past symposium. Click here to get back to the current conference.